Velano Vascular
Velano Vascular developed the PIVO™ needle-free blood collection platform, which advances a flexible tube through existing peripheral IV catheters to enable inpatient blood draws without additional venipuncture. The San Francisco-based medical device company, founded in 2012 and acquired by BD, served hospital systems and integrated delivery networks.
- Company typePrivate
- Founded2012
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Velano Vascular does
Velano Vascular is a San Francisco-based medical device company founded in 2012 that developed the PIVO™ needle-free blood collection platform, a proprietary technology that advances a flexible internal flow tube through existing peripheral IV catheters (PIVCs) to enable high-quality blood draws without additional venipuncture. The technology targets the inpatient hospital setting, where the standard of care requires repeated needle sticks for diagnostic blood collection, and addresses pain, vessel damage, preanalytical specimen errors, and needlestick injury exposure. Velano's commercial portfolio, now sold by Becton, Dickinson and Company following an acquisition, includes the PIVO™ Pro Needle-Free Blood Collection Device (20G and 22G-compatible SKUs), the Nexiva™ Closed IV Catheter System with NearPort™ IV Access, and the ExT™ Stabilized Extension Set, sold together as the BD Peripheral Line Draw Solution.
The company monetized through unit-priced hardware sales to hospital systems and integrated delivery networks via direct enterprise sales, GPO contracting, and value analysis committee engagement. Pricing was negotiated at the system level and not publicly disclosed. Velano accumulated approximately $71.2M in disclosed equity funding across eight rounds from 2013 through 2019, with strategic participation from hospital systems including Intermountain Healthcare, Sutter Health, Griffin Hospital, and The Children's Hospital of Philadelphia. The company built an extensive clinical evidence base, including multi-center studies across 23 hospitals demonstrating 56% reduction in preanalytical errors and 19% reduction in IV replacement rates, a 7,600-draw retrospective review showing 39% lower hemolysis versus venipuncture, and infection-prevention evidence documenting 31.9%-41.8% reduction in hospital-onset bacteremia and fungemia rates.
Post-acquisition by BD, PIVO is sold as part of BD's broader vascular access and medication delivery portfolio through BD's global direct sales force, GPO contracts, customer portals, and the BD Learning Academy training platform. Velano Vascular itself no longer operates as an independent entity; its technology, SKUs, clinical evidence, and customer relationships have been absorbed into BD's enterprise.
Velano Vascular firmographics
Firmographics- Name
- Velano Vascular
- Website
- https://velanovascular.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Velano Vascular developed the PIVO™ needle-free blood collection platform, which advances a flexible tube through existing peripheral IV catheters to enable inpatient blood draws without additional venipuncture. The San Francisco-based medical device company, founded in 2012 and acquired by BD, served hospital systems and integrated delivery networks.
- Ownership category
- akta.pro rank
Velano Vascular industry classification
Industry- Product category
- Vascular Access / Needle-Free Blood Collection Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories) (HLAHAKAE)
- akta.pro secondary industry
- Needle-Free Injection Systems (Jet Injectors/Microneedle Patches) (HLAHAIAD)
Keywords
Where Velano Vascular is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Markets served
Velano Vascular business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Medical Device Sales — PIVO™ Pro and Compatible IV Catheter Systems: Sale of PIVO™ Pro Needle-Free Blood Collection Devices, Nexiva™ Closed IV Catheter Systems, and ExT™ Stabilized Extension Sets to hospital systems and healthcare providers. Revenue is generated through direct hospital procurement and distribution channels, with devices ordered via standard hospital supply chain and GPO contracting processes. Pricing is typically negotiated at system level through value analysis committees.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | PIVO™ Pro Needle-Free Blood Collection Device — 20G compatible |
| Unit Pricing | Pay-as-you-go | PIVO™ Pro Needle-Free Blood Collection Device — 22G compatible |
| Unit Pricing | Pay-as-you-go | Nexiva™ Closed IV Catheter System with NearPort™ IV Access — multiple gauge/length configurations |
| Unit Pricing | Pay-as-you-go | ExT™ Stabilized Extension Set with NearPort™ IV Access — with and without MaxZero™ Connector |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
Velano Vascular product offering
Product offeringCore offering
Velano Vascular developed the PIVO needle-free blood collection platform, a proprietary medical device system that enables high-quality blood draws from existing peripheral IV catheters without additional venipuncture. The portfolio includes the PIVO Pro Needle-Free Blood Collection Device (20G and 22G configurations), the Nexiva Closed IV Catheter System with NearPort IV Access, and ExT Stabilized Extension Sets with optional MaxZero needle-free connectors, sold as the BD Peripheral Line Draw Solution to hospital systems.
Product overview
Velano Vascular (now part of BD) offers the PIVO™ Pro Needle-Free Blood Collection Device, a medical device that enables needle-free blood draws from existing peripheral IV catheters. The product portfolio includes PIVO™ Pro devices in multiple gauge sizes (20G, 22G) and complementary products including the Nexiva™ Closed IV Catheter System with NearPort™ IV Access and ExT™ Stabilized Extension Sets. These products work together as the BD Peripheral Line Draw Solution, designed to reduce needlesticks, improve patient experience, decrease preanalytical errors, and minimize IV catheter replacements. The solution integrates with BD's broader portfolio of blood collection products including BD Vacutainer® Luer-Lok™ Access Device and BD Vacutainer® Blood Collection Tubes.
Differentiator
Problem solved
Functional benefit
Products and services
- PIVO Pro Needle-Free Blood Collection Device (20G compatible) A needle-free blood collection device compatible with 20G IVs that advances a flexible internal flow tube through existing peripheral IV catheters to access optimal draw conditions beyond the catheter tip, enabling high-quality blood draws without additional venipuncture. Targeted at hospital systems, vascular access teams, and phlebotomy services.
- PIVO Pro Needle-Free Blood Collection Device (22G compatible) A needle-free blood collection device compatible with 22G IVs or larger, designed to achieve high-quality blood draws from existing peripheral IV catheter lines without additional venipuncture. Targeted at hospital inpatient settings and patients requiring frequent blood sampling.
- Nexiva Closed IV Catheter System with NearPort IV Access A closed IV catheter system with NearPort IV Access designed to improve peripheral IV catheter dwell times and reduce complications, compatible with the PIVO Pro needle-free blood collection device for integrated vascular access workflows. Targeted at hospital systems and vascular access teams.
- ExT Stabilized Extension Set with NearPort IV Access (without MaxZero Connector) A stabilized extension set with NearPort IV Access enabling the PIVO Pro needle-free blood collection device to be used with traditional short peripheral IV catheters in hospital workflows. Targeted at hospitals using non-integrated catheter systems that want to adopt needle-free blood collection.
- ExT Stabilized Extension Set with NearPort IV Access and MaxZero Needle-free Connector A stabilized extension set with NearPort IV Access and an integrated MaxZero needle-free connector providing a closed-system blood draw workflow with PIVO Pro compatibility for traditional short IV catheters. Targeted at hospitals seeking enhanced safety and closed-system compatibility for needle-free blood collection.
Quantifiable outcome
- 56% decrease in pre-analytical errors
- +9 more outcomes
Companies that use Velano Vascular
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles1 record
Velano Vascular technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Velano Vascular partnerships and signals
Strategic signalScale indicators11 records
Recent moves6 records
Expansion highlights6 records
Velano Vascular competitors and assessment
Company assessmentDirect peers
- ICU Medical: Direct competitor in IV catheters, needle-free connectors, and closed vascular access systems. ICU Medical's acquisition of Smiths Medical expanded its peripheral IV catheter and blood sampling portfolio, putting it in direct competition with the PIVO/Nexiva platform for hospital value-analysis wins.
- B. Braun Medical: Global manufacturer of IV catheters, needle-free connectors, and infusion therapy disposables. B. Braun competes directly with PIVO/Nexiva for inpatient vascular access standardizations and blood draw workflow improvements in hospital systems.
- Teleflex: Vascular access and infusion therapy manufacturer with the Arrow peripheral IV catheter line and needle-safety products. Teleflex targets the same hospital vascular access teams and competes for similar value-analysis committee approvals.
- Vygon: European-headquartered single-use medical devices company with a strong peripheral IV catheter and neonatal/pediatric vascular access portfolio. Vygon competes for hospital vascular access contracts on similar clinical and cost-reduction grounds as Velano/BD's PIVO.
Broad incumbents
- Medline Industries: Large private manufacturer and distributor of medical supplies with an IV therapy and vascular access portfolio. Medline competes for GPO/IDN vascular access and phlebotomy contracts at hospitals considering PIVO adoption.
- Cardinal Health: Major medical product distributor and manufacturer of clinical and surgical supplies including vascular access offerings. Cardinal Health competes at the distribution and contract level for hospital blood collection and vascular access spend.
- Becton, Dickinson and Company (BD): Acquirer of Velano Vascular and now the global marketer of the PIVO platform. BD's Medication Delivery Solutions and Vascular Access Management portfolio includes Nexiva, MaxZero, and Vacutainer products that overlap directly with Velano's pre-acquisition offerings and compete with the same hospital customers.
Emerging players
- Retractable Technologies: Specialty needle-safety device manufacturer offering an alternative pathway to reducing needlestick injuries in hospital blood draw workflows. Competes for the same hospital safety-budget dollars as PIVO, although via a different architectural approach.
- Sarstedt: Family-owned manufacturer of blood collection systems and pre-analytical products serving hospitals and reference labs. Sarstedt competes in the same blood draw workflow that PIVO enables and is often evaluated alongside PIVO for inpatient specimen quality initiatives.
- Greiner Bio-One: Manufacturer of blood collection tubes and pre-analytical products. While not a direct IV catheter competitor, Greiner overlaps with PIVO's downstream workflow of high-quality blood specimen handling and competes for share of hospital phlebotomy supply budgets.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Velano Vascular social profiles
Digital presenceVelano Vascular financial estimates
Financial estimateRevenue estimate
Valuation estimate
Velano Vascular leadership team
Management profileNumber of profiles
Profiles5 records
Velano Vascular funding detail
Funding detailFunding overview
Funding rounds8 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Velano Vascular M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Velano Vascular
What does Velano Vascular do?
Velano Vascular developed the PIVO needle-free blood collection platform, a proprietary medical device system that enables high-quality blood draws from existing peripheral IV catheters without additional venipuncture. The portfolio includes the PIVO Pro Needle-Free Blood Collection Device (20G and 22G configurations), the Nexiva Closed IV Catheter System with NearPort IV Access, and ExT Stabilized Extension Sets with optional MaxZero needle-free connectors, sold as the BD Peripheral Line Draw Solution to hospital systems.
Is Velano Vascular a public or private company?
Velano Vascular is a private company. It is classified as corporate owned and is currently acquired.
When was Velano Vascular founded?
Velano Vascular was founded in 2012. It employs 11 to 50 people.
Where is Velano Vascular based?
Velano Vascular is headquartered in San Francisco, United States, in the North America region.
How does Velano Vascular make money?
One revenue line is on record: medical Device Sales — PIVO™ Pro and Compatible IV Catheter Systems.
Who are Velano Vascular's main competitors?
Direct peers on record are ICU Medical, B. Braun Medical, Teleflex and Vygon. Broad incumbents are Medline Industries, Cardinal Health and Becton, Dickinson and Company (BD). Emerging players are Retractable Technologies, Sarstedt and Greiner Bio-One.
Does Velano Vascular have an API?
No public API is recorded for Velano Vascular.
What industry is Velano Vascular in?
Velano Vascular's product category is Vascular Access / Needle-Free Blood Collection Medical Devices. Its primary akta.pro industry code is HLAHAKAE, Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories), with a secondary code of HLAHAIAD, Needle-Free Injection Systems (Jet Injectors/Microneedle Patches). Its NAICS code is 339112 and its SIC code is 3841.